SC

Sumit Chaudhury

Active Director Director DIN 10115937
DIN 10115937 First appointment Apr 2023 Primary industry Biotechnology
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Apr 2023
Shareholding value •••• Premium profile

About Sumit Chaudhury

Data last updated:

Sumit Chaudhury is a Director at Nutri Pharma Vaccines Private Limited (since 2023). The company operates in Biotechnology. Nutri Pharma Vaccines Private Limited reported revenue of ₹25.69 Cr (FY 2025).

DIN 10115937
Primary Designation Director
Industry Biotechnology
First Appointment 16 Apr 2023
Oldest Company Age 3 yrs
Largest company Nutri Pharma Vaccines Private Limited · ₹25.69 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director16 Apr 20232023₹25.69 Cr (FY 2025)Active

Board colleagues of Sumit Chaudhury

Directorship timeline

Open interactive timeline →
Nutri Pharma Vaccines Private Limited
Premium access

Shareholding and investment profile for Sumit Chaudhury

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sumit Chaudhury

Sumit Chaudhury currently holds 1 directorship: Nutri Pharma Vaccines Private Limited (Director, since 16 Apr 2023, revenue ₹25.69 Cr (FY 2025)).

Sumit Chaudhury was first appointed on 16 Apr 2023 as Director at Nutri Pharma Vaccines Private Limited.

The current boards of Sumit Chaudhury's companies include Prokwana Barman (Nutri Pharma Vaccines Private Limited), Rabindranath Barman (Nutri Pharma Vaccines Private Limited), Spandana Chaudhury (Nutri Pharma Vaccines Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available